Saturday - July 18, 2026
Mirador Therapeutics Expands Precision Immunology Portfolio With Kira Pharmaceuticals Antibody License Agreement
July 18, 2026
BOSTON, Massachusetts, July 18 -- Ropes and Gray, a law firm, issued the following news:

* * *

Mirador Therapeutics Expands Precision Immunology Portfolio with Kira Pharmaceuticals Antibody License Agreement

Ropes & Gray advised Mirador Therapeutics, a precision medicine company developing next-generation therapies for immune-mediated inflammatory and fibrotic diseases, in an exclusive worldwide license agreement with Kira Pharmaceuticals for antibody K . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products